ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Universidad Autónoma de Madrid
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Universidad Autónoma de Madrid (10)
2024
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
2022
-
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709
2021
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092
-
Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091
-
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment
Neurology Perspectives, Vol. 1, pp. S31-S36
2019
-
Spatial distribution of temporalis pressure pain sensitivity in men with episodic cluster headache
International Journal of Environmental Research and Public Health, Vol. 16, Núm. 21
2018
-
Nummular headache: an update and future prospects
Expert Review of Neurotherapeutics, Vol. 18, Núm. 1, pp. 9-19
2016
-
Epicrania Fugax
Current Pain and Headache Reports, Vol. 20, Núm. 4, pp. 1-7
-
Pain Paroxysms with Coronal Radiation: Case Series and Proposal of a New Variant of Epicrania Fugax
Headache, Vol. 56, Núm. 6, pp. 1040-1044
2009
-
Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis
Multiple Sclerosis, Vol. 15, Núm. 11, pp. 1347-1355